ORION NUTRACEUTICALS INC
ORION NUTRACEUTICALS INC
Share · CA68629J2056 · A2P45H (XCNQ)
Overview
No Price
n/a
Share Float & Liquidity
Free Float 98,64 %
Shares Float 28,91 M
Shares Outstanding 29,31 M
Company Profile for ORION NUTRACEUTICALS INC Share
Orion Nutraceuticals Inc. focuses on the drug for treating asthma and chronic obstructive pulmonary diseases in Canada. The company was formerly known as Cline Capital Corp. Orion Nutraceuticals Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Get up to date insights from finAgent about ORION NUTRACEUTICALS INC

Company Data

Name ORION NUTRACEUTICALS INC
Company Orion Nutraceuticals Inc.
Website https://www.orionnutra.ca
Primary Exchange XCNQ CSE LISTED
WKN A2P45H
ISIN CA68629J2056
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Joel S. Dumaresq
Market Capitalization 12 Mio
Country Canada
Currency EUR
Employees -
Address 789 West Pender Street, V6C 1H2 Vancouver
IPO Date 2018-10-17

Ticker Symbols

Name Symbol
CSE LISTED ORI.CN
Frankfurt 86OA.F
More Shares
Investors who hold ORION NUTRACEUTICALS INC also have the following shares in their portfolio:
BPCE S.A. 17/27 MTN REGS
BPCE S.A. 17/27 MTN REGS Bond
NATIONAL EXHIBITION CENTRE (DEVELOPMENTS) PLC 7.5625% GTD UNS LN STK 2027 #(VAR)
NATIONAL EXHIBITION CENTRE (DEVELOPMENTS) PLC 7.5625% GTD UNS LN STK 2027 #(VAR) Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025